Menu

Glyder Device Offers Non-Fusion Option for Facet Pain

Author: Ian C. Langtree - Writer/Editor for Disabled World (DW)
Published: 2014/11/12 - Updated: 2025/12/10
Publication Type: Informative
Category Topic: Clinical Trials - Related Publications

Page Content: Synopsis - Introduction - Main - Insights, Updates

Synopsis: This research covers a clinical feasibility study examining the Glyder Facet Restoration Device, a minimally invasive surgical solution for patients with chronic lumbar facet joint pain who haven't found relief through conservative treatments like injections or nerve blocks. The device consists of two small polymer discs that stabilize the affected facet joint while preserving the spine's natural structure and maintaining options for future treatments - a significant advantage over fusion surgery, which permanently restricts spinal motion. With over 30 percent of chronic low back pain originating from facet joint degeneration and millions of interventions performed annually, this innovation addresses a substantial clinical gap for individuals dealing with debilitating back and leg pain that limits mobility and function - Disabled World (DW).

Introduction

Zyga Technology, Inc., a medical device company focused on the design, development and commercialization of minimally invasive products to treat underserved conditions of the lumbar spine, announced the first patient enrollment in DUET (A Multi-Site Study of the Zyga GlyDer Facet Restoration Device in Subjects with LUmbar FacET Pain Syndrome), a U.S. multi-center single-arm study. The study will be performed at five sites and will include up to 20 patients.

Main Content

"Lumbar" is derived from the Latin word "lumbus," meaning lion, and the lumbar spine earns its name. It is built for both power and flexibility - lifting, twisting, and bending. In human anatomy, the lumbar vertebrae are the five vertebrae between the rib cage and the pelvis. They are the largest segments of the vertebral column and are characterized by the absence of the foramen transversarium within the transverse process (as it is only found in the cervical region), and by the absence of facets on the sides of the body. They are designated L1 to L5, starting at the top. The lumbar vertebrae help support the weight of the body, and permit movement.

Lumbar spinal stenosis is a condition whereby either the spinal canal (central stenosis) or one or more of the vertebral foramina (foraminal stenosis) becomes narrowed. If the narrowing is substantial, it causes compression of the spinal cord or spinal nerves, which causes the painful symptoms of lumbar spinal stenosis, including low back pain, buttock pain, and leg pain and numbness that is made worse with walking and relieved by resting.

"The Glyder device fills a significant gap in the care continuum for facet joint pain," stated Reginald J. Davis, MD, FACS, Chief of Neurosurgery at Greater Baltimore Medical Center, who performed the surgery.

"When conservative treatments such as facet injection or rhizotomy fail to provide relief for these patients, our only recourse has been to perform a fusion, a procedure that eliminates motion and permanently alters the natural movement of the spine. The Glyder Device is designed to provide long-term relief of facet joint pain through a non-fusion procedure that preserves surrounding anatomy and future treatment options."

The Centers for Disease Control and Prevention lists low back pain (LBP) as the second most common cause of disability in U.S. adults (i). It has been reported that over 30 percent of all chronic low back pain derives from the facet joint (ii) , with an estimated 3.2 million facet joint interventions performed annually.

"It is rare and exciting to develop a truly novel technology that fills such a clear unmet clinical need," said Jim Bullock, president and chief executive officer of Zyga. "With the DUET clinical study, as well as a 150-patient Post Market Registry in the E.U. to be launched later this year, we continue to build the clinical evidence needed to support market adoption of the Glyder Facet Restoration Device."

The Glyder Facet Restoration Device is intended to provide relief from lumbar facet pain, restoring facet joint function while preserving native anatomy. The device consists of two small polymer discs that cover the articulating surfaces of the facet joint. The company is currently sponsoring a 20-patient, five-site feasibility study of the Glyder technology in the U.S. and recently received CE Mark on the device.

Zyga Technology is dedicated to the research, development and commercialization of solutions that provide empirical clinical and economic value in the treatment of underserved conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System, a minimally invasive procedure intended for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.

Insights, Analysis, and Developments

Editorial Note: The development of motion-preserving alternatives to spinal fusion represents an important shift in how the medical community approaches chronic back pain, particularly for aging populations and those with degenerative spine conditions. While the DUET study involved a modest 20-patient cohort, the underlying clinical need is undeniable - low back pain remains the second leading cause of disability among American adults. As Zyga continues to build evidence through additional registries and broader adoption in international markets, the Glyder device exemplifies how targeted medical innovation can offer patients genuine choice between procedural options, allowing them to maintain their quality of life without surrendering spinal mobility to achieve pain relief - Disabled World (DW).

Ian C. Langtree Author Credentials: Ian is the founder and Editor-in-Chief of Disabled World, a leading resource for news and information on disability issues. With a global perspective shaped by years of travel and lived experience, Ian is a committed proponent of the Social Model of Disability-a transformative framework developed by disabled activists in the 1970s that emphasizes dismantling societal barriers rather than focusing solely on individual impairments. His work reflects a deep commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his .

Related Publications

: A new nasal candidate vaccine could provide enhanced breadth of protection against emerging SARS-CoV-2 variants.

: Commentary focuses on the importance of including nursing home residents, a population with significant medical complexity, in clinical trials.

: Many low-risk patients with a penicillin allergy were able to have their penicillin allergy label removed through a procedure known as direct oral challenge as part of a world-first multicenter randomized control trial known as the Penicillin Allergy Clinical Decision Rule (PALACE) study.

Share Page
APA: Disabled World. (2014, November 12 - Last revised: 2025, December 10). Glyder Device Offers Non-Fusion Option for Facet Pain. Disabled World (DW). Retrieved February 19, 2026 from www.disabled-world.com/medical/clinical-trials/gfr.php
MLA: Disabled World. "Glyder Device Offers Non-Fusion Option for Facet Pain." Disabled World (DW), 12 Nov. 2014, revised 10 Dec. 2025. Web. 19 Feb. 2026. <www.disabled-world.com/medical/clinical-trials/gfr.php>.
Chicago: Disabled World. "Glyder Device Offers Non-Fusion Option for Facet Pain." Disabled World (DW). Last modified December 10, 2025. www.disabled-world.com/medical/clinical-trials/gfr.php.

While we strive to provide accurate, up-to-date information, our content is for general informational purposes only. Please consult qualified professionals for advice specific to your situation.